Pubblicazioni Peer reviewed articles (11) Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics Autori: Niels Dammes, Meir Goldsmith, Srinivas Ramishetti, Jason L. J. Dearling, Nuphar Veiga, Alan B. Packard & Dan Peer Pubblicato in: Nature Nanotechnology, 2021, ISSN 1748-3387 Editore: Nature Publishing Group DOI: 10.1038/s41565-021-00928-x Therapeutic mRNA delivery to leukocytes Autori: Granot-Matok Y, Kon E, Dammes N, Mechtinger G, and Peer D Pubblicato in: Journal of controlled release, 2019, ISSN 0168-3659 Editore: Elsevier BV DOI: 10.1016/j.jconrel.2019.05.032 Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target Autori: Veiga N, Goldsmith M, Diesendruck Y, Ramishetti S, Rosenblum D, Elinav E, Behlke MA, Benhar I, and Peer D. Pubblicato in: Journal of controlled release, 2019, ISSN 0168-3659 Editore: Elsevier BV DOI: 10.1016/j.jconrel.2019.10.001 rgeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes Autori: Veiga N, Diesendruck Y, and Peer D Pubblicato in: Advanced drug delivery reveiws, 2020, ISSN 0169-409X Editore: Elsevier BV DOI: 10.1016/j.addr.2020.04.002 Engineering Lymphocytes with RNAi Autori: Ramishetti S, and Peer D Pubblicato in: Advanced drug delivery reveiws, 2018, ISSN 0169-409X Editore: Elsevier BV DOI: 10.1016/j.addr.2018.12.002 Progress and challenges towards targeted delivery of cancer therapeutics Autori: Daniel Rosenblum, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Dan Peer Pubblicato in: Nature Communications, Issue 9/1, 2018, ISSN 2041-1723 Editore: Nature Publishing Group DOI: 10.1038/s41467-018-03705-y A modular platform for targeted RNAi therapeutics Autori: Ranit Kedmi, Nuphar Veiga, Srinivas Ramishetti, Meir Goldsmith, Daniel Rosenblum, Niels Dammes, Inbal Hazan-Halevy, Limor Nahary, Shani Leviatan-Ben-Arye, Michael Harlev, Mark Behlke, Itai Benhar, Judy Lieberman, Dan Peer Pubblicato in: Nature Nanotechnology, Issue 13/3, 2018, Page(s) 214-219, ISSN 1748-3387 Editore: Nature Publishing Group DOI: 10.1038/s41565-017-0043-5 Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes Autori: Nuphar Veiga, Meir Goldsmith, Yasmin Granot, Daniel Rosenblum, Niels Dammes, Ranit Kedmi, Srinivas Ramishetti, Dan Peer Pubblicato in: Nature Communications, Issue 9/1, 2018, ISSN 2041-1723 Editore: Nature Publishing Group DOI: 10.1038/s41467-018-06936-1 Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines Autori: Inbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, Shoshy Mizrahy, Brandon D. Ng, Dan Peer Pubblicato in: Journal of Controlled Release, Issue 244, 2016, Page(s) 149-156, ISSN 0168-3659 Editore: Elsevier BV DOI: 10.1016/j.jconrel.2016.07.052 Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes Autori: Shoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, Dalit Landesman-Milo, Dan Peer Pubblicato in: Molecular Therapy, 2017, ISSN 1525-0016 Editore: Nature Publishing Group DOI: 10.1016/j.ymthe.2017.03.001 Monoclonal antibody-based molecular imaging strategies and theranostic opportunities Autori: Niels Dammes, Dan Peer Pubblicato in: Theranostics, Issue 10/2, 2020, Page(s) 938-955, ISSN 1838-7640 Editore: Ivyspring International Publisher DOI: 10.7150/thno.37443 Diritti di proprietà intellettuale Patent (2) MODULAR PLATFORM FOR TARGETED THERAPEUTICS Numero candidatura/pubblicazione: PCT/IB 2017/054334 Data: 2017-07-18 Candidato/i: TEL AVIV UNIVERSITY MODULAR PLATFORM FOR TARGETED THERAPEUTICS Numero candidatura/pubblicazione: PCT/IB 2017/054334 Data: 2017-07-18 Candidato/i: TEL AVIV UNIVERSITY È in corso la ricerca di dati su OpenAIRE... Si è verificato un errore durante la ricerca dei dati su OpenAIRE Nessun risultato disponibile